摘要
目的探究米索前列醇与卡前列素氨丁三醇(欣母沛)治疗产后出血的价值。方法选取产后出血产妇80例,分为两组,分别给予米索前列醇以及欣母沛治疗,对比疗效。结果实验组产后出血产妇疗效、出血量、不良反应发生率等均与对照组产后出血产妇相比,差异具有统计学意义(P<0.05)。结论欣母沛在产后出血中应用,疗效优于米索前列醇,可促进产妇出血量的减少,且安全性较高。
Objective To explore the value of misoprostol and carboprost tromethamine（hemabate） for treatment of postpartum hemorrhage. Methods Select 80 cases of maternal postpartum hemorrhage, divided into 2 groups, respectively give misoprostol and hemabate treatment, compare the curative effect. Results Experimental maternal postpartum hemorrhage curative effect, the bleeding risk, adverse reactions such as maternal postpartum hemorrhage compared to control group, significant difference（P〈0.05）. Conclusion Hemabate used in postpartum hemorrhage, curative effect is better than that of misoprostol, can promote the decrease of maternal blood loss, and high safety.
出处
《中国卫生标准管理》
2017年第3期66-67,共2页
China Health Standard Management
